A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.
Not Applicable
Recruiting
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000007427
- Lead Sponsor
- Division of Gastroenterology, Department of Medicine Kurume University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
An infectious disease of the activity (but except the viral hepatitis) An overlap cancer of the activity A past of sensitivity to iodocontrast media A pregnant woman, a nursing girl may be pregnant The case that the medical attendant judged to be inappropriate as an object of the final examination for reasons of others (problem cases such as a patient does not hear instructions or the support of the family not being provided)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of this study is the overall survival time.
- Secondary Outcome Measures
Name Time Method